mvvp banner red border
HomeThe Team PortfolioLimited Partners Co-InvestorsNews ArticlesContact Us

MVVP logo




Sunovion Pharmaceuticals completes acquisition of Elevation Pharmaceuticals, September 2012

Pankaj Singhal, Ph.D. appointed Senior Vice President of Global Operations at Biomatrica, June 2012

Biomatrica expands product portfolio for preserving biological samples at ambient temperatures, June 2012

Lineagen completes 9000-person study focused on genetic variants in individuals diagnosed with autism spectrum disorder, May 2012

Lineagen presents data showing clinical utilization of FirstStep Dx, a new model of genetic service delivery, at the 2012 American College of Medical Genetics and Genomics annual clinical genetics meeting, March 2012

Lineagen applies Affymetrix' GeneChip technology to next-generation FirstStep Dx service for individuals with developmental delay and autism spectrum disorders, March 2012

West Penn Allegheny Health System announces results of clinical trials of Exagen's Avise-SLE test for diagnosis of Systemic Lupus Erythematosus, February 2012

Exagen Diagnostics announces the launch of Avise SLE, a breakthrough Lupus Diagnostic, January 2012

Tech News Frontiers, January 2011 - Medipacs polymer platform

FierceBiotech, January 2010 ?Elevation Pharmaceuticals raises $30 million in Series A Financing

BIOCOM Newsletter Cover Story, November 2009 ?Medipacs among first to be selected into EvoNexus Incubator

Analysts on the conference call were replica watches uk curious why Arden felt the need for Rh cash at the expense of diluting shareholders replica watches. We think the question should be replica watches turned around. What does Rh see in a chanel replica company that replica handbags was made much sport of for blaming its Justin Beiber and Taylor Swift replica louis vuitton celebrity brands for the fiscal fourth quarter's much worse than chanel replica expected revenue and earnings results?

Phoenix Business Journal, December 2008 - Medipacs Named Best of Show at Invest Southwest

BioSpace Newswire Release: Traversa Raises $2M to Advance RNAi Delivery in Angel-Led Series A Financing. February 4, 2008

BioSpace Newswire Release: LineaGen Inc. Launches With Close of $5.8 Million Series A Funding Round. December 19, 2007

Mesa Verde Venture Partners of San Diego lead $700,000 Series A financing for Satiogen Pharmaceuticals. October 2007

Golden State BioBusiness News: Seed / Start-up Biomedical Investing in the Southwest. Volume X No. 9 October 2007

San Diego Business Journal August 27, 2007 Dan Wood article